Cognition Therapeutics Inc banner

Cognition Therapeutics Inc
NASDAQ:CGTX

Watchlist Manager
Cognition Therapeutics Inc Logo
Cognition Therapeutics Inc
NASDAQ:CGTX
Watchlist
Price: 0.8174 USD -2.42% Market Closed
Market Cap: $72.2m

Profitability Summary

Cognition Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Cognition Therapeutics Inc

Margins Comparison
Cognition Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Cognition Therapeutics Inc
NASDAQ:CGTX
72.7m USD
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
879.7B USD
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.1B USD
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
232B GBP
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
295.2B USD
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
229.9B CHF
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
116.1B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Cognition Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Cognition Therapeutics Inc
NASDAQ:CGTX
72.7m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
879.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
232B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
295.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
229.9B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
116.1B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Cognition Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett